Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: May 31, 2011 (rev. 1)

Premium

Husband and wife Neal Copeland and Nancy Jenkins will join the Methodist Hospital Research Institute in Texas as co-directors of cancer biology at the institute and at the Methodist Cancer Center. They were the first researchers to be recruited through Texas' Cancer Prevention and Research Institute, which was established by state voters in 2007. Copeland and Jenkins have identified genes associated with leukemia, lymphoma, melanoma, pancreatic, lung, breast, and prostate cancers.

The couple previously spent five years at Singapore's Agency for Science, Technology, and Research. Additionally, they have worked at the Jackson Laboratory, and also the National Cancer Institute-Frederick, where Copeland headed the molecular genetics of oncogenesis and Jenkins headed the molecular genetics of development.

Copeland holds a PhD in biochemistry from the University of Utah and Jenkins holds a PhD in molecular and cellular biology from Indiana University.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.